Alvesco Aerosol, Metered
NDC Package 70515-712-01
Package Information
Alvesco (ciclesonide) aerosols is aLVESCO is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 12 years of age and older.Limitations of Use: ALVESCO is not indicated for the relief of acute bronchospasm.ALVESCO is not indicated for children under 12 years of age. This formulation utilizes a aerosol, metered delivery system. Marketed by Covis Pharma Us, Inc, this product is identified by NDC 70515-712 and is authorized under FDA application NDA021658.
Identification & Billing
- RxCUI: 799034 - ciclesonide 160 MCG/INHAL Metered Dose Inhaler, 60 Actuations
- RxCUI: 799034 - 60 ACTUAT ciclesonide 0.16 MG/ACTUAT Metered Dose Inhaler
- RxCUI: 799034 - ciclesonide 160 MCG/ACTUAT Metered Dose Inhaler, 60 ACTUAT
- RxCUI: 799037 - Alvesco 160 MCG/INHAL Metered Dose Inhaler, 60 Actuations
- RxCUI: 799037 - 60 ACTUAT ciclesonide 0.16 MG/ACTUAT Metered Dose Inhaler [Alvesco]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70515 - Covis Pharma Us, Inc
- 70515-712 - Alvesco
- 70515-712-01 - 1 INHALER in 1 CARTON / 60 AEROSOL, METERED in 1 INHALER
- 70515-712 - Alvesco
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70515-712). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70515-712-01 identifies a specific commercial package of 1 inhaler in 1 carton / 60 aerosol, metered in 1 inhaler of Alvesco, a human prescription drug labeled by Covis Pharma Us, Inc. This aerosol, metered is formulated for respiratory (inhalation) use and contains ciclesonide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Covis Pharma Us, Inc on March 26, 2018. The current certification is valid through December 31, 2026.
How is this Covis Pharma Us, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70515071201. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.